![Kenneth Anderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Anderson
Founder at
C4 THERAPEUTICS, INC.
Net worth: 2 M $ as of 31/05/2026
Profile
Kenneth C.
Anderson is the founder of Acetylon Pharmaceuticals, Inc., founded in 2008, serving as Director since 2008.
Dr. Anderson is the founder of C4 Therapeutics, Inc., founded in 2015, serving as Independent Director since 2015.
Dr. Anderson is the founder of NextRNA Therapeutics, Inc., founded in 2021, serving as Director since 2021.
Dr. Anderson is also the founder of Dynamic Cell Therapies, Inc...
Dr. Anderson is currently Director-Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute, Inc. Dr. Anderson is Director at The Multiple Myeloma Research Foundation, Inc. since 2011.
Dr. Anderson is Director at Mana Therapeutics, Inc. since 2018.
Dr. Anderson is Director at Raqia Therapeutics, Inc. since 2020.
Dr. Anderson is Director at Starton Therapeutics, Inc. since 2020.
Dr. Anderson is a Member of the National Academy of Medicine (United States).
Dr. Anderson is Professor at Harvard Medical School since 2002.
Former positions include Chairman at Multiple Myeloma Research Consortium, Chairman at National Comprehensive Cancer Network, Inc., Director at OncoPep, Inc., President at American Society of Hematology, and President at International Myeloma Society from 2011 to 2015.
Education includes a doctorate from The Johns Hopkins University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/06/2026 | 355,585 ( 0.32% ) | 2 M $ | 31/05/2026 |
Kenneth Anderson active positions
| Companies | Position | Start |
|---|---|---|
| C4 THERAPEUTICS, INC. | Founder | 01/01/2015 |
The Multiple Myeloma Research Foundation, Inc.
 The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Director/Board Member | - |
Raqia Therapeutics, Inc.
 Raqia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops and manufactures oncology therapeutics | Director/Board Member | 01/09/2020 |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Founder | 01/02/2021 |
Starton Therapeutics, Inc.
 Starton Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on transforming therapies with delivery technology | Director/Board Member | 01/09/2020 |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2002 |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Corporate Officer/Principal | 01/12/2010 |
Mana Therapeutics, Inc.
 Mana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical cell immune therapies that can eliminate cancer cells | Director/Board Member | 01/01/2018 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Former positions of Kenneth Anderson
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Kenneth Anderson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
OncoPep, Inc.
 OncoPep, Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Commercial Services |
Multiple Myeloma Research Consortium
 Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Provides research and drug development | Commercial Services |
National Comprehensive Cancer Network, Inc.
 National Comprehensive Cancer Network, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to fight against cancer | Commercial Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technology | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Mana Therapeutics, Inc.
Mana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical cell immune therapies that can eliminate cancer cells | Commercial Services |
Raqia Therapeutics, Inc.
Raqia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops and manufactures oncology therapeutics | Commercial Services |
International Myeloma Society
 International Myeloma Society The International Myeloma Society is a professional, scientific, and medical organization dedicated to advancing research, education, and clinical care related to multiple myeloma and plasma cell disorders. The private company is based in Rochester. The society brings together basic scientists, clinical investigators, physicians, and healthcare practitioners worldwide to promote collaboration and knowledge exchange through workshops, conferences, symposia, and educational events. It provides membership benefits such as access to meeting materials, member directories, and newsletters, and supports the myeloma community by funding translational and career development research awards. The society addresses disparities in treatment access through programs like the Therapeutic Map, which offers region-specific drug availability guidelines for clinicians. It organizes annual meetings and thematic sessions with expert talks and collaborative discussions with regulatory agencies, focusing on topics such as genomics and novel therapies. | |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on transforming therapies with delivery technology | Health Technology |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Health Technology |
Dynamic Cell Therapies, Inc.
 Dynamic Cell Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pre-clinical stage biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Kenneth Anderson
